New Combination Respiratory Therapy for COPD Approved by FDA

A new double-combination therapy that promotes lung expansion and airway clearance has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of people with lung diseases including chronic obstructive pulmonary disease (COPD) and asthma. The therapy was developed by the Monaghan Medical Corporation  and combines two…

Real-world Study of COPD Patients Shows Nondrug Aerobika Device Reduces Exacerbations

Positive results from a real-world study were recently presented evaluating the effectiveness of the Aerobika Oscillating PEP nondrug device in reducing chronic obstructive pulmonary disease (COPD) exacerbations. Trudell Medical International presented the results of the study at the European Respiratory Society (ERS) International Congress Sept. 3-7 in London. Trudell…